|
|
Volumn , Issue , 2009, Pages 507-519
|
|
Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY CONJUGATE;
ANTINEOPLASTIC AGENT;
CAC10 VCMMAE;
CAC10-VCMMAE;
CELL SURFACE RECEPTOR;
ENZYME INHIBITOR;
HYDROXAMIC ACID;
IMMUNOTOXIN;
MONOCLONAL ANTIBODY;
NEW DRUG;
PANOBINOSTAT;
TUMOR PROTEIN;
ADOPTIVE IMMUNOTHERAPY;
ADULT;
AUTOTRANSPLANTATION;
DISEASE FREE SURVIVAL;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HODGKIN DISEASE;
HUMAN;
IMMUNOTHERAPY;
MULTIMODALITY CANCER THERAPY;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SALVAGE THERAPY;
SCINTISCANNING;
STATISTICS;
TREATMENT OUTCOME;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS, PHASE II AS TOPIC;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUGS, INVESTIGATIONAL;
ENZYME INHIBITORS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HODGKIN DISEASE;
HUMANS;
HYDROXAMIC ACIDS;
IMMUNOCONJUGATES;
IMMUNOTHERAPY;
IMMUNOTHERAPY, ADOPTIVE;
IMMUNOTOXINS;
NEOPLASM PROTEINS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECEPTORS, CELL SURFACE;
SALVAGE THERAPY;
TRANSPLANTATION, AUTOLOGOUS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 77949463615
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2009.1.507 Document Type: Review |
|
Times cited : (53)
|
|
References (118)
|
